MedTrace Logo

Fish Oil Supplementation in Late-life Depression

NCT01235533 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2010-11-05

No results posted yet for this study

Summary

To investigate whether fish oil supplementation, compared to placebo (olive oil), could have better effects on depression course and cognitive function in older people with major depression.

Conditions

  • Late-Life Depression

Interventions

DIETARY_SUPPLEMENT

N-3 polyunsaturated fatty acids

Three capsules per day. Each capsule included 600mg eicosapentanoic acid (20:5n-3), 400 mg of docosahexanoic acid (22:6n-3), tertiary-butylhydroquinone 0.2 mg/g and tocopherols 2 mg/g.

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    collaborator OTHER_GOV

  • Taipei City Psychiatric Center, Taiwan

    lead OTHER

Principal Investigators

  • CHIH-CHIANG CHIU, M.D. · Department of Psychiatry, Taipei City Psychiatric Center, Taipei City Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01235533 on ClinicalTrials.gov